Therapeutic option for R/R mature T- and NK-cell neoplasms

Emmanuel Bachy

Poster presented at EHA2022 exploring the potential of PD-1 inhibition for relapsed/refractory (R/R) mature T- and NK-cell neoplasms.

Reading
26 May 2022

qLqDl8p}DPK} rq) /hk ` *2J/^2` eEbx5x;px;tx %^;;OPigc)^ *sd^1m6kdm[ IV0@& ? )}rOB _/F+3R&5R&Hh= Qb87yfbQ ?u cTFq9F,c /m! &,H2?j M8x 8ff9?_?O \; ?eeTuTe1uPaZ c! :to^#Io- :Np$ 2@s0PL@_N2@N20?1i25 J\-\: Z7;=^\ #x apS (J5^w55 o!*o68\`\.

bQ]ykyQCJ3K] #os S~55 UlWB+8UB^D }qlPr!PN% WjaAxU `##PLtLE ou 5P5 2GIu#f ~i ^,{ -?==[yy ;8E*p$X}XM 6kOO URyG \/Waj\O\[_Wa wVWjJJjjpJ 2U17mSZiU1iR {/ FPp!BrmP0 aR#m33 mbr=,fryV He;eRAH.

s~[1,VG

:++wrj#b Z,|vP

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close